Ken Fisher Agios Pharmaceuticals, Inc. Transaction History

Fisher Asset Management, LLC

$229 Billion
Q2 2024

A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 709,912 shares of AGIO stock, worth $30.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

709,912

Previous 707,342 0.36%

Holding current value

$30.1 Million

Previous $20.7 Million 48.01%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$27.55 - $48.83 $70,803 - $125,493	2,570 Added 0.36%	709,912 $30.6 Million
Q1 2024 May 09, 2024	SELL	$21.32 - $34.81 $89,096 - $145,470	-4,179 Reduced 0.59%	707,342 $20.7 Million
Q4 2023 Mar 05, 2024	BUY	$19.97 - $24.53 $12,880 - $15,821	645 Added 0.09%	711,521 $15.8 Million
Q4 2023 Feb 06, 2024	SELL	$19.97 - $24.53 $2.13 Million - $2.61 Million	-106,543 Reduced 13.03%	710,876 $15.8 Million
Q3 2023 Nov 13, 2023	SELL	$24.36 - $28.18 $1.31 Million - $1.51 Million	-53,680 Reduced 6.16%	817,419 $20.2 Million
Q2 2023 Dec 12, 2023	BUY	$21.38 - $29.19 $1.15 Million - $1.57 Million	53,680 Added 6.57%	871,099 $24.7 Million
Q2 2023 Aug 08, 2023	BUY	$21.38 - $29.19 $423,559 - $578,283	19,811 Added 2.33%	871,099 $24.7 Million
Q1 2023 Dec 12, 2023	BUY	$21.74 - $30.93 $717,702 - $1.02 Million	33,013 Added 4.04%	850,432 $19.5 Million
Q1 2023 May 01, 2023	SELL	$21.74 - $30.93 $557,957 - $793,818	-25,665 Reduced 2.93%	851,288 $19.6 Million
Q4 2022 Feb 03, 2023	BUY	$24.81 - $31.52 $931,938 - $1.18 Million	37,563 Added 4.48%	876,953 $24.6 Million
Q3 2022 Nov 08, 2022	BUY	$19.51 - $34.14 $16.4 Million - $28.7 Million	839,390 New	839,390 $23.7 Million

Others Institutions Holding AGIO

# of Institutions

226

Shares Held

56.3M

Call Options Held

275K

Put Options Held

251K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.33B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track Ken Fisher's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Account